Tele-Epilepsy Market Size, Share, and Industry Analysis, By Type (Services and Products), By Age (Adults and Pediatrics), By Modality (Store-and-forward (Asynchronous), Real-time (Synchronous), and Others), By End-user (Healthcare Facilities, Home Care, and Others), and Regional Forecast, 2026-2034

The global tele-epilepsy market size was valued at USD 562.24 million in 2025. The market is projected to grow from USD 658.16 million in 2026 to USD 2320.59 million by 2034, exhibiting a CAGR of 17.06% during the forecast period.

The global tele-epilepsy market is witnessing significant growth due to the rise in the prevalence of epilepsy worldwide. The tele-epilepsy is the branch of telemedicine technology used for epilepsy care, seizure activity monitoring, remote diagnosis, etc. Epilepsy is a chronic, non-communicable disease that requires constant monitoring to control seizures. Additionally, there is a rise in demand for remote monitoring and an increase in the awareness of telehealth, which is expected to drive market growth.

• For instance, according to the World Health Organization, in February 2024, approximately 50.0 million people globally had epilepsy, and 80% of them are living in low- and middle-income countries. This rise in prevalence with an increase in healthcare costs is expected to drive the growth of the tele-epilepsy market during the forecast period. 

Tele-Epilepsy Market Driver

Rise in Prevalence of Epilepsy Boosts the Market Growth

The growing prevalence of epilepsy significantly drives market growth. This prevalence is rising due to the aging population and conditions such as stroke and dementia. Additionally, a rise in awareness about telehealth services and a rise in demand for remote monitoring also support market growth. Moreover, the advancement in technology, such as the development of seizure tracking devices further expected to boost the market growth. 

• For instance, NeuroPace, Inc., in August 2021, launched a new platform, nSight, and collaborated with Seizure Tracker to provide patients’ personalized information to doctors. This type of technological advancement increases the adoption of tele-epilepsy services, which drives the growth of the market.

Prevalence of Genetic Epilepsy, By Key Countries (2021)

According to the data published in The Lancet in 2021, there were 51.7 million people had epilepsy across the globe. In the population, active epilepsy affected about 0.7% of the global population in 2021, with the majority of cases (over 80%) concentrated in low- to middle-income countries, where the incidence and mortality rates were significantly higher compared to high-income regions.

Tele-Epilepsy Market Restraint

Lack of Technological Infrastructure Can Limit Market Growth

The availability of networks and quality of telecommunications infrastructure in remote or rural areas can reduce the reach and effectiveness of tele-epilepsy services, which is expected to hinder market growth. Moreover, lack of awareness of tele-epilepsy technology among patients and data privacy concerns also lower the market growth. 

• For instance, according to the data published by the World Economic Forum in September 2023, in developing countries, only 35% of people have any form of online access. Such a connectivity problem may hinder the market growth during the forecast period.

Tele-Epilepsy Market Opportunity

Rise in Demand for Remote Healthcare Solutions Will Boost Market Growth in the Future

In recent years, to track health, smartphone and wearable devices have been used. The tele-epilepsy also includes these types of wearable devices and user-friendly applications & platforms. Thus, this technological shift will drive the market growth in the future. 

• For instance, in November 2024, the Empatica Health Monitoring Platform run by Empatica Inc added a new EpiMonitor Diary for health monitoring, which collects real-time data. These types of platforms attract patients to track their health and enhance market growth. 

Key Insights

The report covers the following key insights:

• Overview: Reimbursement Scenario
• Prevalence of Epilepsy, By Key Countries
• Technological Advancement 
• Internet Penetration Statistics, By Key Countries
• New Product Launches, By Key Players
• Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
• Impact of COVID-19 on the Market

Segmentation

Analysis by Type

Based on the type, the market is segmented into services and products. 

The services segment is expected to grow significantly during the forecast period. The growth of the segment is augmented by the rise in awareness among patients about tele-epilepsy consultation and user-friendly platforms. Tele-epilepsy services include virtual consultation, remote diagnosis, seizure monitoring, etc., which increases the adoption of tele-epilepsy Services and boosts the market growth during the forecast period.

• For instance, according to the data published in the International League Against Epilepsy in July 2022, tele-epilepsy services such as video calls help to solve complicated cases by epilepsy specialists and also help to train general practitioners. Thus, it raises the adoption of tele-epilepsy services and drives the segment growth in the market. 

Analysis by Age

Based on age, the market is segmented into adults and pediatrics. 

The adult segment held a significant share of the market in 2024. A significant share of the segment is due to the rise in the prevalence of epilepsy among adults, due to adults suffering from various conditions such as stroke, brain tumor, and dementia. These conditions increase the risk of epilepsy in adults. Thus, the rise in the prevalence of epilepsy among adults boosts the market growth during the forecast period. 

• For instance, according to the data published on Epilepsy & Behavior in 2021, 1.1% of U.S. adults had active epilepsy, and 0.6% of adults had inactive epilepsy. This rise in the prevalence of epilepsy among adults drives the growth of the market. 

Analysis by Modality

By modality, the market is segmented into (store-and-forward (asynchronous), real-time (synchronous), and others.

The store-and-forward segment (Asynchronous) accounted for the major portion of the tele-epilepsy market in 2024. The growth is due to the rise in the virtual diagnosis rate of epilepsy. Moreover, the rise in internet penetration rate increases the virtual treatment and virtual health monitoring, which helps to enhance market growth. 

• For instance, according to the data published on Arquivos de neuro-psiquiatria in November 2022, more than 70% of epilepsy cases do not require in-person evaluation and can be treated through telemedicine. Such awareness is expected to boost the adoption of tele-epilepsy products and services over the projected years. 

Analysis by End-user

By end-user, the market is segmented into healthcare facilities, home care, and others. 

The healthcare facilities segment held a substantial share of the market. The rise in government support for the use of tele-epilepsy and telecommunication tools among hospitals drives the growth of the segment. Additionally, the rise in virtual Services providers enhances market growth.

• For instance, in October 2022, Medyseva, an Indian healthtech start-up, raised USD 0.17 million in pre-series funding to expand access to telemedicine in rural India. This significant investment in the expansion of telemedicine in rural areas is anticipated to increase the adoption of tele epilepsy services, which will further boost market growth.

Regional Analysis

By region, the market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America.

Request for Customization   to gain extensive market insights.

North America accounted for a substantial share of the global tele-epilepsy market in 2024. The region's growth is augmented by the increasing prevalence of epilepsy and the presence of advanced technological infrastructure. Moreover, the presence of advanced healthcare facilities for better treatment options also drives the growth of the market in this region. 

• For instance, according to the U.S. Centers for Disease Control and Prevention, in May 2024, in the U.S., approximately 3.0 million adults had epilepsy. Such high prevalence in the region and increasing focus on convenient solutions are expected to increase the demand for tele-epilepsy in North America. 

Europe has a considerable share of the global tele-epilepsy market. The growth of the region is due to the rise in demand for remote health monitoring. Additionally, favorable regulatory policies, government support for using digital health, and a rise in the prevalence of epilepsy further boost the market growth in Europe. 

Asia Pacific is expected to grow substantially in the forthcoming years. This growth will be attributed to the rise in the prevalence of epilepsy in this region. Additionally, increasing investments in healthcare facilities and digital health are expected to boost the market significantly in the region.

Key Players Covered

The global tele-epilepsy market is fragmented, with small and medium players operating at the regional level. The report will include the profiles of the following key players: 

• Shimmer (Europe)
• Empatica Inc. (U.S.)
• Real Time Tele-Epilepsy Consultants (U.S.)
• Orlando Epilepsy Center (U.S.)
• Sevaro Health, Inc. (New York)
• TeleSpecialists (U.S.)
• Ceribell, Inc. (U.S.)

Key Industry Developments

• In October 2023, Ceribell, Inc. launched its new AI algorithm, ClarityPro; it has the availability of additional reimbursement for medicare patients. It is an AI-based software system that helps to analyze EEG waveforms; it helps in the diagnosis of epilepsy. 
• In January 2021, UCB announced the launch of Nile AI, Inc., a digital health company, for the development of a digital epilepsy care management platform to collect epilepsy data for prediction.